Showing 15 posts of 141 posts found.


GE Healthcare doubles India investment

September 21, 2016
Manufacturing and Production, Research and Development, Sales and Marketing GE Healthcare, India

UK firm GE Healthcare is set to double its investment in India as it aims for revenues of £750 million …


MHRA suspends GMP certificate for Pfizer site in India

August 22, 2016
Manufacturing and Production, Sales and Marketing GMP, India, MHRA, Pfizer, ban, facility, import, suspend

The UK’s Medicines and Healthcare Products Agency (MHRA) has recommended that an Indian facility belonging to Pfizer’s Hospira unit be …


Opdivo and Keytruda set for India launches by end of year

August 8, 2016
Sales and Marketing India, keytruda, launch, opdivo

Indian cancer patients could be set to receive two of the world’s leading oncology drugs, MSD’s Keytruda and Bristol-Myers Squibb’s …


Gilead’s Sovaldi gets Indian patent; critics call it “major blow” to patient access

May 11, 2016
Manufacturing and Production, Research and Development, Sales and Marketing India, harm, hepatitis, patent, patient access, sovaldi

Gilead has been granted a patent for its hepatitis C drug, Sovaldi (sofosbuvir), in India which has sparked dismay among …


FDA, WHO criticise integrity of data at contract research firm Semler

April 25, 2016
Research and Development, Sales and Marketing FDA, India, WHO, World Health Organisation, semler, semler research

The US Food and Drug Administration and the World Health Organisation have raised serious concerns related to violations of good …


Roche sues Intas Pharma over patent dispute in India

April 18, 2016
Medical Communications, Sales and Marketing India, Roche, anaemia, chronic kidney, intas, intas pharmaceuticals, patent

Roche Pharmaceuticals is suing Indian-based Intas Pharmaceuticals, alleging that the company has infringed upon its patent rights to anaemia drug, …


Sun Pharma agree deal to distribute AstraZeneca type-2 diabetes drug in India

March 24, 2016
Sales and Marketing AstraZeneca, India, Sun Pharma, diabetes, oxra, type 2, type-2

Sun Pharma has agreed a deal with AstraZeneca to promote and distribute their type-2 diabetes drug, dapagliflozin, in India. Marketed …

Celgene logo

Celgene settles Revlimid patent dispute

December 23, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Celgene, India, Natco, Revlimid, lenalidomide, patents

Celgene has settled its litigation with Natco Pharma, over the patents for Revlimid, opening the door to increased generic competition …

Sun Pharma logo

Pharma companies look to boost employee retention

November 27, 2015
Medical Communications HR, India, Jobs, recruitment

Drug firms in India are devising novel ‘benching’ models to manage employee turnover. Attrition rates for pharma companies in India …

FDA warnings create woe for Indian drugmakers

November 10, 2015
Manufacturing and Production CGMP, Dr Reddy's, Dr. Reddy's, FDA, India, Sun Pharma, manufacturing, production

Recent enforcement action has taken its toll on the fortunes of several Indian pharmaceutical manufacturers, with Sun Pharmaceuticals and Dr. …

GSK begins work on £100m India facility

September 9, 2015
Manufacturing and Production GlaxoSmithKline, India, manufacturing

GSK has begun work on its new Rs. 1000 crore (£100m) pharmaceutical factory in Vemgal, southern India. When fully operational …

Novartis and Pfizer to close factories in India

July 21, 2015
Manufacturing and Production India, Novartis, Pfizer, Sandoz, manufacturing

Two big pharma firms have announced they will close manufacturing facilities in India as they seek to restructures their global …


FDA bans drug imports from Indian plant

July 21, 2015
Manufacturing and Production Emcure, FDA, GMP, Good Manufacturing Practices, India, compliance, manufacturing, production, safety

The FDA has blocked US imports from the manufacturing plants of a major Indian pharmaceutical firm over safety fears. The …

sun pharma image

Sun Pharma sacks 18 Ranbaxy executives

June 19, 2015
Manufacturing and Production, Sales and Marketing Daiichi, India, Ranbaxy, Sun Pharma, brett wells

Sun Pharma has asked 18 executives to leave the company who were previously a part of Ranbaxy, the firm it …

MSF campaigns to uphold cheap Indian generics

June 12, 2015
Manufacturing and Production, Sales and Marketing Doctors Without Borders, India, MSF, Médecins Sans Frontières

Charity Médecins Sans Frontières is urging Indian prime minister Narendra Modi to stand tall and not give in to pressure …

Latest content